Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Best Momentum Stock to Buy for December 7th
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, December 7th:
Aquestive Therapeutics (AQST - Free Report) : This specialty pharmaceutical company which, commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 72.0% over the last 60 days.
Aquestive Therapeutics, Inc. Price and Consensus
Aquestive Therapeutics, Inc. price-consensus-chart | Aquestive Therapeutics, Inc. Quote
Aquestive Therapeutics’ shares gained 30.4% over the last three month compared with the S&P 500’s gain of 2.5%. The company possesses a Momentum Score of A.
Aquestive Therapeutics, Inc. Price
Aquestive Therapeutics, Inc. price | Aquestive Therapeutics, Inc. Quote
Viad Corp (VVI - Free Report) : This international experiential services company with operations in the United States, Canada, the United Kingdom, continental Europe and the United Arab Emirates, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its next year earnings increasing 44.8% over the last 60 days.
Viad Corp Price and Consensus
Viad Corp price-consensus-chart | Viad Corp Quote
Viad Corp’s shares gained 28.1% over the last three month compared with the S&P 500’s gain of 2.5%. The company possesses a Momentum Score of B.
Viad Corp Price
Viad Corp price | Viad Corp Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.